Introduction: The goal of the study was an evaluation of serum vitamin D concentrations in healthy young women. Material and methods: A total of 106 healthy women, aged 20-30 years, were included in the study. Monthly evaluation -for three months -of the effects of calcium (500 mg) and vitamin D (1500 IU) administration in women with baseline values of vitamin D < 20 ng/mL (Group 1) plus the effects of an 800 IU/d dose in women with the baseline value of D > 20 ng/mL (Group 2). Additionally, calcium and PTH concentrations were assessed at the study onset and after a three-month supplementation. Only 67 women adhered to the prescribed therapeutic regime during the three months of observation.
Introduction
Calcium is a mineral component that is very important not only for the skeleton structure but also as a nutrient, required for nerve conduction, muscle contraction, hormone and enzyme secretion, and blood clotting. An adequate calcium intake is essential for normal growth and development of the skeleton and teeth and also for adequate bone mineralisation. Optimised bone mass accretion in youth and adolescence is critical to attaining peak bone mass in adulthood [1] . In adulthood, low calcium intake is associated with an increased risk for osteoporosis [2] , bone fractures, and falls [3, 4] . The Institute of Medicine supports the key combined role of calcium and vitamin D in the maintenance of skeletal health, recommending a daily intake of 1.2 g of calcium and 800 IU of vitamin D for women in their prime [5] .
Vitamin D helps calcium absorption and its role in bone health has been well characterised [6] . Vitamin D and calcium are necessary for proper modelling and remodelling of bones and the optimal bone mass depends on their appropriate supplementation. Vitamin D is also responsible for modulation of cell growth, neuromuscular and immune function, and reduction of inflammation [7] . It has been shown that high-dose vitamin D3 significantly reduced CD4+ T-cell activation compared to low-dose vitamin D3, providing human evidence that vitamin D can influence cell-mediated immunity [8] .
Apart from maintaining adequate serum calcium and phosphate concentrations, there is some evidence that vitamin D may help prevent colon, prostate, and breast cancers [7] . Vitamin D deficiency may contribute to certain chronic diseases [9] . It may also play an important role in the prevention and treatment of diabetes [10, 11] , cardiovascular disease [12] , chronic heart failure and autoimmune diseases (e.g. multiple sclerosis, chronic thyroiditis, ulcerative colitis) [13] , mental illnesses, such as depression [14] , schizophrenia [15, 16] , neurodevelopmental disorders, and intellectual disabilities [17] .
In humans, the major volumes of circulating vitamin D are synthesized from cholesterol, following exposure to sunlight ultraviolet B, whereas a smaller amount is derived from diet and dietary supplements. Diet contributes only between 10% and 20% to 25(OH)D levels, but becomes more important when sunshine exposure is low [18] . Calcium in the diet contributes to about 50% of the recommended intake [5] .
Vitamin D deficiency and insufficiency are respectively defined as 25(OH)D levels < 20 ng/mL (50 nmol/L) and 25(OH)D between 20 and 29 ng/mL (50 nmol/L and 75 nmol/L), although different definitions exist [19] . In Europe, the mean serum 25(OH)D levels, reported in population-based studies, vary from 18 ng/mL (29 nmol/L) in Italy to 30 ng/mL (75 nmol/L) in Norway [20] . It has been observed that more than 40% of U.S. and European men and women, and more than 50% of postmenopausal women, are affected by vitamin D deficiency [7, 21] , including Poland, where it is found in approximately 90% of the general population [22] [23] [24] . In some populations, the deficit is ever stronger, e.g. 98.8% of Mongolian women, 18-44 years of age, demonstrate serum 25(OH)D < 20 ng/mL (50 nmol/L) [25] . There are some factors that can influence the deficiency of vitamin D, e.g. in the Swiss adult population, the prevalence of vitamin D insufficiency or deficiency is high and varies by season, BMI category, and speaking region. The association of speaking regions with vitamin D status is independent of major potential confounders [21] .
Gahche et al. have shown that vitamin D supplements have increased over time in adult populations, while their consumption by children and adolescents appears to be stable [26] . The daily contribution of supplemental calcium in the United States (2005) (2006) for women at the age of 19-30 years was 283 ± 18.7 mg/dL and the daily intake of vitamin D was 7.5 ± 0.7 ug. Calcium intake from diet, demonstrated by women at the age of 19-30 years, was 945 ± 29.8 mg/d and vitamin D intake was 5.8 ± 0.3 ug/d [27] .
The goal of the study was an evaluation of serum vitamin D concentration in healthy women, aged 20-30 years, and to update the prevalence of vitamin D deficiency and insufficiency, defined as vitamin D Total (25(OH)D) less or more than 20 ng/mL. Additionally, in one-month evaluation -for three months -the effects of calcium (500 mg) and vitamin D (800 IU or 1500 IU) supplementation were evaluated.
Material and methods
A total number of 106 healthy females, aged 20-30 years, were enrolled into the study. The women were assigned to two groups, depending on baseline serum level of vitamin D. Group 1 was composed of women with baseline vitamin D concentrations below 20 ng/mL and the rest of the study population formed Group 2. All the participants received daily oral supplementation of calcium (calcium carbonate) in a dose of 1250 mg and vitamin D3 in a dose of 1500 IU (Group 1) or 800 IU (Group 2) for three months. Calcium and vitamin D3 supplements were provided free of charge by their manufacturer (Axellus LLC). The adherence to therapy was assessed on the basis of patient declarations and returned empty drug packaging units. In cases of non-compliance to visit schedules, the patients were contacted by phone.
The women who were qualified to the study paid visits every month in order to replenish their supplement stock, for evaluation of compliance with prescribed supplement administration schedules and regimes and for planned examinations. Blood samples were collected from fasting patients at the inclusion visit and after 1, 2, and 3 months to assay total vitamin D, total calcium, phosphates, and alkaline phosphatase concentrations and after three months to assay parathormone (PTH) level. In order to exclude thyroid dysfunction, an additional blood sample was collected for baseline TSH assay.
The women' height and weight were measured and BMIs were calculated twice (at enrolment and after three months) in all the patients. All the enrolled patients remained under care of the Outpatient Clinic of Endocrinology throughout the whole study period.
Only 67 women adhered to therapy during the three months of observation and completed the study.
Laboratory tests
Biochemical assays were carried out by means of the following methods and sets: 1. Serum alkaline phosphatase concentrations, as well as total serum calcium and phosphate levels, were assessed using a colorimetric method with an 
Statistical analysis
The study data are presented as means, means ± SD, and means ± SEM. For all statistical analyses, the level of significance (p value) was determined at 0.05. Data distribution normality was checked in each group, using the Shapiro-Wilk's test.
In cases where there was no reason to reject the hypothesis that the distribution is normal, ANOVA with repeated measures was used. However, in cases of non-normal distribution, we used the Friedman test (or the Wilcoxon test for comparing two points). The Newman-Keuls test was used to compare significant differences between time points. The Spearman's rank correlation coefficient test was employed to evaluate correlations between assessed parameters.
In order to compare changes in vitamin D levels in relation to the categorised groups according to their baseline levels and their changes in time periods, twoway repeated measure analysis of variance (ANOVA) was applied. In case of categorised measurements, the variables were independent. During ANOVA procedures, not only simple effects were verified (e.g. the dependence between variable increase or decrease in terms of individual effect), but also interactions of effects were examined.
Results
In our study, the mean concentration of total vitamin D in the whole group was 16.56 ng/mL. During each month, we observed increased concentrations of this vitamin: the highest above 30 ng/mL after three months (Tab. I).
Vitamin D concentration changes for all the examined women at three time points of supplementation were statistically significant. We also observed significant differences between vitamin D levels in the second and third month, in comparison to its concentration in the first and second month of supplementation (Fig. 1) .
Statistically significant changes in PTH were observed between baseline and after 3 months of supplementation (Tab. II and Fig. 2) . 
Figure 2. Changes in PTH concentration at baseline and after 3 months of supplementation

Rycina 2. Zmiany stężenia PTH po 3 miesiącach suplementacji w porównaniu z wartościami początkowymi
In whole group, no correlation was observed between changes in PTH and vitamin D concentrations and between changes in BMI and vitamin D (data not shown).
In Group 1 (patients with baseline total vitamin D level < 20 ng/mL), which was supplemented with daily dose of 500 mg of calcium and 1500 IU of vitamin D, we observed a statistically significant increase in vitamin D throughout the whole study period (Tab. III). Significant differences were noticed between vitamin D levels in the second and third month, in comparison to its concentrations in the first month of supplementation (see Fig. 3 ). The highest rise of vitamin D was seen after the first month of its supplementation.
In Group 2 (patients with baseline total vitamin D level > 20 ng/mL), which was supplemented with daily dose of 500 mg of calcium and 800 IU of vitamin D, we also noticed a statistically significant increase of vitamin D throughout the whole study period (see Table IV ).
The increase of vitamin D during three months was not as great as in the group of women with deficit and deficiency of vitamin D (< 20 ng/mL). In that group, significant differences were noticed among vitamin D levels in the third month in comparison to its concentration in the first and the second month of supplementation (Fig. 4) . 1 at 4 time points: 0 -at baseline; 1 -after 1 month; 2 -after 2 
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We also compared vitamin D level changes in relation to categorised groups, according to their baseline levels (0-10 ng/mL; 10-20 ng/mL; > 20 ng/mL) and their changes over time periods. The increase of vitamin D concentrations in the group 0-10 ng/mL was significantly higher than that in the other two groups (10-20 and > 20 ng/mL) in all the examined time periods. The rise of vitamin D levels in group 10-20 ng/mL in comparison to group > 20 ng/mL was insignificant during any of the time periods (Tab. V and Fig. 5 ).
Discussion
Vitamin D and calcium deficiencies are preventable global public health problems in infants, children, and adolescents. According to international rickets prevention 
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programs, implementation, including supplementation and food fortification, is an urgently required measure [28, 29] . The role of adequate calcium and vitamin D intake benefits in health and the prevention of several chronic diseases has been the main focus for many scientists in the past few decades. Most of the observations have shown a positive influence of supplementation [13, 17] . Some facts, which indicate that not only osteoporosis, but also obesity, cancer, diabetes, hypertension, and others may be linked to inadequate calcium and vitamin D metabolism [30] [31] [32] [33] [34] [35] , suggests an extraordinary potential in these two agents [36] . However, some authors raise the question of whether the role of calcium and vitamin D is overweighed [37] .
The Institute of Medicine supports the key role of calcium and vitamin D in the maintenance of skeletal health and recommended a daily intake of 1.2 g of calcium and 800 IU of vitamin D for women in older age [5] . In Poland, 90% of people have insufficiency of vitamin D [23, 24, 38] .
The goal of our study was to examine vitamin D concentrations in a population of young, healthy women and to evaluate the optimal dose of vitamin D supplementation. Daily supplementation of calcium in the United States for women aged 19-30 years is 283 ± 18.7 mg/dL and daily intake of vitamin D 7.5 ± 0.7 ug (300 ± 28 IU) [27] . In our study, the women, aged 20-30 years, were divided into two groups depending on total vitamin D concentration at baseline. Serum total vitamin D consists of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. In Poland, there is no vitamin D2 in tablets. Our source of this vitamin is thus limited to diet. In Group 1, which received supplementation of 1250 mg of calcium carbonicum and 1500 IU vitamin D for three months, the concentration of total vitamin D increased by about 16 ng/mL from 12.60 ± 0.71 ng/mL to 29.42 ± 1.01 ng/mL. Similarly, in Group 2, which received 1250 mg of calcium carbonicum and a supplementation of 800 IU vitamin D for three months, the concentration of vitamin D total increased by about 12 ng/mL from 25.22 ± 0.93 ng/mL to 36.92 ± 1.46 ng/mL. The study was started in January and finished in May. It is comparable with other observations. In a study of 112 white women, aged 19 to 35 years, randomly assigned to placebo or 800 IU/d vitamin D3 for one year, : baseline and after 1 month (1), after 2 months (2), and after 3 month (3 [41, 42] . Vitamin D3 supplementation with 1000 IU/d in children (aged 8-14 years) with mean baseline 25(OH)D concentration < 20 ng/mL effectively raised their mean 25(OH)D concentration to ≥ 20 ng/mL but failed to reach 30 ng/mL. In this paper vitamin D supplementation had no effect on PTH concentrations [43] .
Other findings from our study include serum PTH drops after vitamin D intake. In the young women in Group 1, PTH decreased from 38.03 ± 1.69 to 28.85 ± 1.37 (p < 0.0001). In our observations, no correlation was identified between PTH and total vitamin D.
Other authors did find a significant inverse correlation between serum 25OHD and PTH [44, 45] , but their examined populations were larger. There might also be another explanation for this. Shieh et al. observed that the percentage change in iPTH was significantly associated with change in free (but not total) vitamin D, without and with adjustment for supplementation regimen [46] . They suggested that vitamin D3 increased total (25-hydroxyvitamin D2 and 25-hydroxyvitamin D3) and free 25(OH)D levels to a greater extent than vitamin D2. Free 25(OH)D may be superior to total 25(OH)D as a marker of vitamin D bioactivity.
We did not see any side effects during calcium and vitamin D supplementation. The women in our groups were young (20-30 years old). It was confirmed that the incidence of hypercalciuria and hypercalcaemia is lower in younger women than that reported for older women [47, 48] .
Our study authorises us to make a recommendation for the population of young women in Poland. A dose of vitamin 1500 IU/d increases total serum vitamin D concentration by 17 ng/mL, whereas 800 IU/d increases serum 25OHD by 12 ng/mL in young white women. Recently, the IOM suggested that RDA for people at the age group 19 to 50 years should be 600 IU/d [5] . In Poland, according to our recommendations, the dose of vitamin D should be higher [49] , especially in case of its deficiency, which is often seen in younger populations who are still building peak bone mass.
